The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 9, 2006, Pages 1118-1123

  Hyams, Jeffrey ^a   Markowitz, James ^b   Lerer, Trudy ^a   Griffiths, Anne ^c   Mack, David ^e   Bousvaros, Athos ^d   Otley, Anthony ^f   Evans, Jonathan ^g   Pfefferkorn, Mariann ^h   Rosh, Joel ⁱ   Rothbaum, Robert ^k   Kugathasan, Subra ^j   Mezoff, Adam ^l   Wyllie, Robert ^m   Tolia, Vasundhara ⁿ   delRosario, J Fernando ^o   Moyer, M Susan ^q   Oliva Hemker, Maria ^p   LeLeiko, Neal ^r  

^a Farmington   (United States)

^b North Shore Long Island Jewish Health System ^*  (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f IWK HEALTH CENTRE   (Canada)

^g NEMOURS CHILDREN S CLINIC   (United States)

^h RILEY HOSPITAL FOR CHILDREN   (United States)

ⁱ MORRISTOWN MEMORIAL HOSPITAL   (United States)

^j ST LOUIS CHILDREN S HOSPITAL   (United States)

^k MEDICAL COLLEGE OF WISCONSIN   (United States)

^l CHILDREN S MEDICAL CENTER   (United States)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^o NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^p CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^q JOHNS HOPKINS HOSPITAL   (United States)

^r HASBRO CHILDREN'S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; MESALAZINE; TACROLIMUS;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; EARLY INTERVENTION; ENTERITIS; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; CANADA; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; REGISTRIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 33748210698     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.04.008     Document Type: Article

References (15)

1. Truelove S.C., and Witts L.J. Cortisone in ulcerative colitis; final report on a therapeutic trial. BMJ 4947 (1955) 1041-1048
2. Kornbluth A., Sachar D.B., American College of Gastroenterology, and Practice Parameters Committee. Ulcerative colitis practice guidelines in adults. Am J Gastroenterol 92 (1997) 204-211
3. Escher J.C., Taminiau J.A., Nieuwenhuis E.E., et al. Treatment of inflammatory bowel disease in childhood: best available evidence. Inflamm Bowel Dis 9 (2003) 34-58
4. Faubion Jr. W.A., Loftus Jr. E.V., Harmsen W.S., et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121 (2001) 255-260
5. Hyams J.S., Davis P., Grancher K., et al. Clinical outcome of ulcerative colitis in children. J Pediatr 129 (1996) 81-88
6. Kugathasan S., Judd R.H., Hoffmann R.G., et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 143 (2003) 525-531
7. Schachter H., and Kirsner J.B. Definitions of inflammatory bowel disease of unknown etiology. Gastroenterology 68 (1975) 591-600
8. Farrell R.J., Murphy A., Long A., et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118 (2000) 279-288
9. Honda M., Orii F., Ayabe T., et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118 (2000) 859-866
10. Bantel H., Domschke W., Schulze-Osthoff K., et al. Abnormal activation of transcription factor NF-kappaB involved in steroid resistance in chronic inflammatory bowel disease. Am J Gastroenterol 95 (2000) 1845-1846
11. Sandborn W.J., Landers C.J., Tremaine W.J., et al. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 71 (1996) 431-436
12. Jarnerot G., Hertervig E., Friis-Liby I., et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128 (2005) 1805-1811
13. Rutgeerts P., Feagan B., and Olson A. A randomized placebo-controlled trial of infliximab for active ulcerative colitis: ACT 1 trial. Gastroenterology 128 (2005) A105
14. Sandborn W.J., Rachmilewitz D., and Hanauer S.B. Infliximab induction and maintenance therapy for ulcerative colitis: the ACT 2 trial. Gastroenterology 128 (2005) A104
15. Mamula P., Markowitz J.E., Cohen L.J., et al. Infliximab in pediatric ulcerative colitis: two-year follow-up. J Pediatr Gastroenterol Nutr 38 (2004) 298-301